Literature DB >> 31645265

Blood doping: Then and now. A narrative review of the history, science and efficacy of blood doping in elite sport.

Thomas S Atkinson1, Marc J Kahn2.   

Abstract

As the line between excellent and exceptional athletic performance narrows and as the financial remuneration for exceptional performance increases, unscrupulous athletes and their trainers will strive to enhance performance regardless of cost. One method of performance enhancement is by the augmentation of the oxygen-carrying capacity of the blood through blood doping. We discuss the science behind erythropoiesis and means by which these processes can be exploited to the potential advantage of the athlete. These include pre-sport transfusion practices as well as supplemental recombinant human erythropoietin (rHuEpo) and the use of newer erythropoietic agents, many of which have not received FDA approval. Finally, we discuss the data behind the efficacy of blood doping in an attempt to discern whether or not the practice actually works to improve athletic and competitive performance.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood doping; Erythropoietin; Oxygen delivery; Sports hematology

Year:  2019        PMID: 31645265     DOI: 10.1016/j.blre.2019.100632

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  2 in total

1.  Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion.

Authors:  Amna Al-Nesf; Nada Mohamed-Ali; Vanessa Acquaah; Maneera Al-Jaber; Maryam Al-Nesf; Mohamed A Yassin; Nelson N Orie; Sven Christian Voss; Costas Georgakopoulos; Rikesh Bhatt; Alka Beotra; Vidya Mohamed-Ali; Mohammed Al-Maadheed
Journal:  Metabolites       Date:  2022-05-10

2.  Identification of RNA Markers in Red Blood Cells for Doping Control in Autologous Blood Transfusion.

Authors:  Takehito Sugasawa; Yasuharu Kanki; Ritsuko Komine; Koichi Watanabe; Kazuhiro Takekoshi
Journal:  Genes (Basel)       Date:  2022-07-15       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.